Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Ani Pharmaceuticals' FCF Payout Ratio history spans 5 years, with the latest figure at 0.01 for Q3 2025.

  • On a quarterly basis, FCF Payout Ratio fell 99.44% to 0.01 in Q3 2025 year-over-year; TTM through Dec 2025 was 0.01, a 75.46% decrease, with the full-year FY2025 number at 0.01, down 75.46% from a year prior.
  • FCF Payout Ratio hit 0.01 in Q3 2025 for Ani Pharmaceuticals, up from 0.01 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for ANIP hit a ceiling of 1.62 in Q3 2024 and a floor of 0.09 in Q4 2022.
  • Historically, FCF Payout Ratio has averaged 0.11 across 5 years, with a median of 0.01 in 2025.
  • Biggest five-year swings in FCF Payout Ratio: tumbled 477.97% in 2022 and later soared 12072.0% in 2024.
  • Tracing ANIP's FCF Payout Ratio over 5 years: stood at 0.02 in 2021, then tumbled by 477.97% to 0.09 in 2022, then surged by 109.09% to 0.01 in 2023, then skyrocketed by 74.82% to 0.01 in 2024, then tumbled by 34.87% to 0.01 in 2025.
  • Business Quant data shows FCF Payout Ratio for ANIP at 0.01 in Q3 2025, 0.01 in Q2 2025, and 0.01 in Q1 2025.